Our team of experts brings you cancer-related news and research updates.
Cancers in adolescents and young adults (AYAs)—in ages 15 to 39—are the focus of a new report published in CA: A Cancer Journal for Clinicians on September 17, 2020. The researchers looked at rates and trends by sex and race/ethnicity, across 3 smaller age groups: Ages 15 to 19 (referred to as adolescents or teens), ages 20 to 29, and ages 30 to 39.
For the second time, the US Food and Drug Administration (FDA) has approved a drug to treat tumors with a specific genetic change regardless of the type of cancer. Vitrakvi (larotrectinib) is for adults and children with solid tumors that test positive for NTRK genes, which can help cancerous tumors grow.
The US Food and Drug Administration (FDA) has approved a combination of 2 targeted drugs to treat people with anaplastic thyroid cancer that has a certain type of gene mutation (BRAF V600E) and cannot be completely removed through surgery.
Cowden disease is a type of PTEN hamartoma tumor syndrome (PHTS) caused by a mutation in the PTEN gene. PHTS raises the risk of developing certain types of cancer, including skin, thyroid, breast, endometrial, colorectal, and kidney.
Luke Soderling says the lessons he learned from facing the challenges of thyroid cancer helped him to survive 60 days in 6 different harsh locations in South America, on the Discovery Channel show, The Wheel.